Coagulation and fibrinolysis during the infusion of Corynebacterium parvum in man.
作者信息
Cederholm-Williams S A, King A, Allington M J, Gill P G, Sharp A A, Britton B J
出版信息
Br J Cancer. 1978 Jun;37(6):1074-7. doi: 10.1038/bjc.1978.155.
Abstract
摘要
相似文献
1
Coagulation and fibrinolysis during the infusion of Corynebacterium parvum in man.人输注短小棒状杆菌过程中的凝血与纤溶
Br J Cancer. 1978 Jun;37(6):1074-7. doi: 10.1038/bjc.1978.155.
2
Hypercoagulability after immunotherapy with Corynebacterium parvum in man.人用短小棒状杆菌免疫治疗后的高凝状态。
Blut. 1982 Apr;44(4):241-7. doi: 10.1007/BF00319910.
3
4
Immunotherapy of cancer with corynebacterium parvum.用短小棒状杆菌进行癌症免疫疗法。
Ann Allergy. 1978 Mar;40(3):155-7.
5
Effects of Corynebacterium parvum vaccine in conjunction with immunosuppression in renal transplant in dogs.短小棒状杆菌疫苗联合免疫抑制在犬肾移植中的作用。
Transplantation. 1982 Mar;33(3):333-5. doi: 10.1097/00007890-198203000-00028.
6
Surgery plus Corynebacterium parvum immunotherapy for Lewis lung carcinoma in mice.手术联合微小棒状杆菌免疫疗法治疗小鼠Lewis肺癌
Eur J Cancer (1965). 1979 Jun;15(6):867-73. doi: 10.1016/0014-2964(79)90228-7.
7
[The use of Corynebacterium parvum in pleurodesis].[短小棒状杆菌在胸膜固定术中的应用]
Duodecim. 1988;104(4):262-5.
8
Lung cancer patients treated with Corynebacterium parvum. Phase I toxicity study.用短小棒状杆菌治疗肺癌患者。I期毒性研究。
Minn Med. 1979 Sep;62(9):673-5.
9
Antitumor activity of Corynebacterium parvum.短小棒状杆菌的抗肿瘤活性。
Adv Cancer Res. 1978;26:257-306. doi: 10.1016/s0065-230x(08)60090-1.
10
[Immunotherapy with Corynebacterium parvum in experimental influenza virus infections and mixed infections in mice].
Pol Tyg Lek. 1986 May 12;41(19):619-23.
引用本文的文献
1
Effect of intravenous corynebacterium parvum on peripheral-blood effector cells of cancer patients.静脉注射短小棒状杆菌对癌症患者外周血效应细胞的影响。
Br J Cancer. 1980 May;41(5):782-9. doi: 10.1038/bjc.1980.142.
2
Single versus multiple human-equivalent doses of C. parvum in mice: neutralization of the anti-metastatic effect.小鼠中单次与人等效剂量的微小隐孢子虫对比多次与人等效剂量的微小隐孢子虫：抗转移作用的中和
Br J Cancer. 1980 Mar;41(3):407-14. doi: 10.1038/bjc.1980.64.
3
Mechanisms of C. Parvum-induced coagulopathy in mice.微小隐孢子虫诱导小鼠凝血病的机制。
Br J Cancer. 1980 Jan;41(1):117-22. doi: 10.1038/bjc.1980.13.
4
Hypercoagulability after immunotherapy with Corynebacterium parvum in man.人用短小棒状杆菌免疫治疗后的高凝状态。
Blut. 1982 Apr;44(4):241-7. doi: 10.1007/BF00319910.
本文引用的文献
1
FIBRINOLYTIC PROPERTIES OF PROTEASES DERIVED FROM HUMAN, DOG AND RABBIT LEUKOCYTES.源自人、狗和兔白细胞的蛋白酶的纤溶特性。
Thromb Diath Haemorrh. 1964 Jan 1;10:379-89.
2
TREATMENT OF MALIGNANT DISEASE WITH PROTAMINE SULPHATE.用硫酸鱼精蛋白治疗恶性疾病
Lancet. 1964 Feb 22;1(7330):408-9. doi: 10.1016/s0140-6736(64)92787-4.
3
Factors affecting the development of metastatic cancer. Effect of alterations in clottin mechanism.
Cancer. 1962 Mar-Apr;15:276-83. doi: 10.1002/1097-0142(196203/04)15:2<276::aid-cncr2820150211>3.0.co;2-g.
4
Studies on enhanced fibrinolytic activity in man.关于人类纤维蛋白溶解活性增强的研究。
J Clin Invest. 1959 May;38(5):810-22. doi: 10.1172/JCI103863.
5
The fibrin plate method for estimating fibrinolytic activity.用于评估纤维蛋白溶解活性的纤维蛋白平板法。
Arch Biochem Biophys. 1952 Oct;40(2):346-51. doi: 10.1016/0003-9861(52)90121-5.
6
Blood coagulation and the generalized Shwartzman reaction.血液凝固与全身性施瓦茨曼反应。
Thromb Diath Haemorrh Suppl. 1966;20:107-19.
7
Gelation of soluble fibrin in plasma by ethanol.乙醇使血浆中的可溶性纤维蛋白发生凝胶化。
Scand J Haematol. 1966;3(5):342-50. doi: 10.1111/j.1600-0609.1966.tb02378.x.
8
Evaluation of a rapid method for the determination of plasma fibrinogen.血浆纤维蛋白原测定快速方法的评估
J Clin Pathol. 1970 Feb;23(1):43-6. doi: 10.1136/jcp.23.1.43.
9
A study of the mechanism by which anticoagulation with warfarin inhibits blood-borne metastases.一项关于华法林抗凝抑制血行转移机制的研究。
Cancer Res. 1973 Jun;33(6):1217-24.
10
Coagulation changes of septic shock in the sub-human primate and their relationship to hemodynamic changes.亚人类灵长类动物脓毒性休克的凝血变化及其与血流动力学变化的关系。
Ann Surg. 1972 Mar;175(3):417-23. doi: 10.1097/00000658-197203000-00015.
Zotero 插件